

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 6.11084637 |
| 2 | lysine catabolic process (GO:0006554) | 6.11084637 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.78062240 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.78062240 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.72507850 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.72507850 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.37356322 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.22517765 |
| 9 | cysteine metabolic process (GO:0006534) | 5.13282256 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.09914595 |
| 11 | 2-oxoglutarate metabolic process (GO:0006103) | 4.94632911 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.86351331 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.82056909 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.82056909 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.82056909 |
| 16 | aspartate family amino acid catabolic process (GO:0009068) | 4.80758163 |
| 17 | amino-acid betaine metabolic process (GO:0006577) | 4.78764257 |
| 18 | regulation of translational fidelity (GO:0006450) | 4.75574998 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.75388886 |
| 20 | proline biosynthetic process (GO:0006561) | 4.74299200 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73022582 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.71626819 |
| 23 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.69378816 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 4.68815084 |
| 25 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.66670064 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 4.63812302 |
| 27 | tricarboxylic acid cycle (GO:0006099) | 4.63024040 |
| 28 | DNA strand elongation (GO:0022616) | 4.54495520 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.50746924 |
| 30 | bile acid biosynthetic process (GO:0006699) | 4.50481015 |
| 31 | valine metabolic process (GO:0006573) | 4.43011930 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 4.41237295 |
| 33 | glycine metabolic process (GO:0006544) | 4.40640420 |
| 34 | DNA unwinding involved in DNA replication (GO:0006268) | 4.39557489 |
| 35 | fatty acid oxidation (GO:0019395) | 4.32625942 |
| 36 | acetyl-CoA metabolic process (GO:0006084) | 4.31686275 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.31651511 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.31431415 |
| 39 | branched-chain amino acid catabolic process (GO:0009083) | 4.31120837 |
| 40 | urea metabolic process (GO:0019627) | 4.30516529 |
| 41 | urea cycle (GO:0000050) | 4.30516529 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.29422110 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.27890018 |
| 44 | lipid oxidation (GO:0034440) | 4.23409434 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 4.21190854 |
| 46 | carnitine metabolic process (GO:0009437) | 4.20405370 |
| 47 | fatty acid transmembrane transport (GO:1902001) | 4.16759048 |
| 48 | fatty acid catabolic process (GO:0009062) | 4.16674504 |
| 49 | regulation of protein activation cascade (GO:2000257) | 4.13806960 |
| 50 | negative regulation of fibrinolysis (GO:0051918) | 4.12602472 |
| 51 | carnitine shuttle (GO:0006853) | 4.11076117 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 4.10946285 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.08403674 |
| 54 | branched-chain amino acid metabolic process (GO:0009081) | 4.05587523 |
| 55 | DNA replication initiation (GO:0006270) | 4.04760673 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.99628288 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 3.97193300 |
| 58 | oxaloacetate metabolic process (GO:0006107) | 3.96979176 |
| 59 | tricarboxylic acid metabolic process (GO:0072350) | 3.95227138 |
| 60 | monocarboxylic acid catabolic process (GO:0072329) | 3.94943301 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 3.93223048 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.91200924 |
| 63 | regulation of complement activation (GO:0030449) | 3.88988049 |
| 64 | triglyceride homeostasis (GO:0070328) | 3.88104065 |
| 65 | acylglycerol homeostasis (GO:0055090) | 3.88104065 |
| 66 | aromatic amino acid family metabolic process (GO:0009072) | 3.86571935 |
| 67 | tetrahydrofolate metabolic process (GO:0046653) | 3.85252662 |
| 68 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.85037333 |
| 69 | ethanol oxidation (GO:0006069) | 3.84725420 |
| 70 | L-serine metabolic process (GO:0006563) | 3.84543621 |
| 71 | organic acid catabolic process (GO:0016054) | 3.84070888 |
| 72 | carboxylic acid catabolic process (GO:0046395) | 3.84070888 |
| 73 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.83618618 |
| 74 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.81945338 |
| 75 | NADH metabolic process (GO:0006734) | 3.81287215 |
| 76 | ketone body metabolic process (GO:1902224) | 3.80103214 |
| 77 | regulation of sequestering of triglyceride (GO:0010889) | 3.80077257 |
| 78 | protein carboxylation (GO:0018214) | 3.80073444 |
| 79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.80073444 |
| 80 | succinate metabolic process (GO:0006105) | 3.79040304 |
| 81 | coenzyme catabolic process (GO:0009109) | 3.77227577 |
| 82 | bile acid metabolic process (GO:0008206) | 3.76340440 |
| 83 | glutamate metabolic process (GO:0006536) | 3.76117479 |
| 84 | regulation of fibrinolysis (GO:0051917) | 3.75280606 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72454572 |
| 86 | DNA replication checkpoint (GO:0000076) | 3.66648323 |
| 87 | biotin metabolic process (GO:0006768) | 3.61912581 |
| 88 | regulation of fatty acid oxidation (GO:0046320) | 3.61364537 |
| 89 | folic acid metabolic process (GO:0046655) | 3.60657386 |
| 90 | cellular glucuronidation (GO:0052695) | 3.57702129 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 3.56391619 |
| 92 | proline metabolic process (GO:0006560) | 3.54330719 |
| 93 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.54212799 |
| 94 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.48389892 |
| 95 | plasma lipoprotein particle clearance (GO:0034381) | 3.47091745 |
| 96 | dicarboxylic acid metabolic process (GO:0043648) | 3.46335605 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45627254 |
| 98 | protein-lipid complex remodeling (GO:0034368) | 3.45627254 |
| 99 | macromolecular complex remodeling (GO:0034367) | 3.45627254 |
| 100 | reverse cholesterol transport (GO:0043691) | 3.45139491 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 3.43781227 |
| 102 | COPI coating of Golgi vesicle (GO:0048205) | 3.43781227 |
| 103 | nuclear pore complex assembly (GO:0051292) | 3.43102906 |
| 104 | benzene-containing compound metabolic process (GO:0042537) | 3.42542977 |
| 105 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.39589329 |
| 106 | folic acid-containing compound metabolic process (GO:0006760) | 3.39503985 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.39434444 |
| 108 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.39336169 |
| 109 | regulation of cholesterol esterification (GO:0010872) | 3.39178413 |
| 110 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.37950394 |
| 111 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.37414075 |
| 112 | fatty acid homeostasis (GO:0055089) | 3.34163504 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.33602120 |
| 114 | tyrosine metabolic process (GO:0006570) | 3.33031370 |
| 115 | regulation of cholesterol metabolic process (GO:0090181) | 3.31680795 |
| 116 | negative regulation of sterol transport (GO:0032372) | 3.31437896 |
| 117 | negative regulation of cholesterol transport (GO:0032375) | 3.31437896 |
| 118 | mitotic sister chromatid segregation (GO:0000070) | 3.31289758 |
| 119 | mitotic chromosome condensation (GO:0007076) | 3.28069549 |
| 120 | tRNA methylation (GO:0030488) | 3.28066783 |
| 121 | indolalkylamine metabolic process (GO:0006586) | 3.27704158 |
| 122 | tRNA aminoacylation for protein translation (GO:0006418) | 3.27693397 |
| 123 | IMP biosynthetic process (GO:0006188) | 3.27412701 |
| 124 | DNA synthesis involved in DNA repair (GO:0000731) | 3.26580522 |
| 125 | NAD metabolic process (GO:0019674) | 3.25949407 |
| 126 | formation of translation preinitiation complex (GO:0001731) | 3.25804574 |
| 127 | amino-acid betaine transport (GO:0015838) | 3.23663114 |
| 128 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.23149348 |
| 129 | telomere maintenance via recombination (GO:0000722) | 3.23087244 |
| 130 | tRNA aminoacylation (GO:0043039) | 3.19139631 |
| 131 | amino acid activation (GO:0043038) | 3.19139631 |
| 132 | ribosomal small subunit biogenesis (GO:0042274) | 3.18927557 |
| 133 | pseudouridine synthesis (GO:0001522) | 3.18043193 |
| 134 | maturation of 5.8S rRNA (GO:0000460) | 3.16241896 |
| 135 | IMP metabolic process (GO:0046040) | 3.15935606 |
| 136 | rRNA transcription (GO:0009303) | 3.13816114 |
| 137 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.13110987 |
| 138 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.12769718 |
| 139 | ribosome assembly (GO:0042255) | 3.12404998 |
| 140 | nucleobase biosynthetic process (GO:0046112) | 3.09543832 |
| 141 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.05880045 |
| 142 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.05880045 |
| 143 | nuclear pore organization (GO:0006999) | 3.03357224 |
| 144 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.00023565 |
| 145 | regulation of mitochondrial translation (GO:0070129) | 2.98395275 |
| 146 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.93863657 |
| 147 | peptidyl-histidine modification (GO:0018202) | 2.93762605 |
| 148 | sister chromatid segregation (GO:0000819) | 2.92296594 |
| 149 | positive regulation of chromosome segregation (GO:0051984) | 2.90265831 |
| 150 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.88975932 |
| 151 | pteridine-containing compound metabolic process (GO:0042558) | 2.88863088 |
| 152 | regulation of translational termination (GO:0006449) | 2.88649964 |
| 153 | histone arginine methylation (GO:0034969) | 2.88114771 |
| 154 | mitotic nuclear envelope disassembly (GO:0007077) | 2.87525367 |
| 155 | rRNA modification (GO:0000154) | 2.86503592 |
| 156 | ribosome biogenesis (GO:0042254) | 2.85713144 |
| 157 | mitochondrial fusion (GO:0008053) | 2.82285669 |
| 158 | regulation of translational elongation (GO:0006448) | 2.82234024 |
| 159 | mitotic recombination (GO:0006312) | 2.81785769 |
| 160 | negative regulation of mRNA processing (GO:0050686) | 2.81592629 |
| 161 | viral mRNA export from host cell nucleus (GO:0046784) | 2.81111143 |
| 162 | mitochondrial RNA metabolic process (GO:0000959) | 2.80021816 |
| 163 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.77411670 |
| 164 | ribosomal large subunit biogenesis (GO:0042273) | 2.74914634 |
| 165 | DNA duplex unwinding (GO:0032508) | 2.72454094 |
| 166 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.70065652 |
| 167 | peptidyl-arginine N-methylation (GO:0035246) | 2.67601048 |
| 168 | peptidyl-arginine methylation (GO:0018216) | 2.67601048 |
| 169 | protein complex localization (GO:0031503) | 2.66298295 |
| 170 | alpha-amino acid biosynthetic process (GO:1901607) | 2.66262243 |
| 171 | sulfur amino acid biosynthetic process (GO:0000097) | 2.66195642 |
| 172 | tRNA modification (GO:0006400) | 2.65570020 |
| 173 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.65252918 |
| 174 | maturation of SSU-rRNA (GO:0030490) | 2.63219303 |
| 175 | membrane disassembly (GO:0030397) | 2.61135347 |
| 176 | nuclear envelope disassembly (GO:0051081) | 2.61135347 |
| 177 | telomere maintenance via telomere lengthening (GO:0010833) | 2.60832170 |
| 178 | DNA geometric change (GO:0032392) | 2.60326062 |
| 179 | protein localization to chromosome, centromeric region (GO:0071459) | 2.59433621 |
| 180 | mitotic metaphase plate congression (GO:0007080) | 2.59326918 |
| 181 | gluconeogenesis (GO:0006094) | 2.59218736 |
| 182 | protein K6-linked ubiquitination (GO:0085020) | 2.58923496 |
| 183 | rRNA processing (GO:0006364) | 2.55710787 |
| 184 | GDP-mannose metabolic process (GO:0019673) | 2.55126717 |
| 185 | pore complex assembly (GO:0046931) | 2.54979967 |
| 186 | monosaccharide biosynthetic process (GO:0046364) | 2.54289816 |
| 187 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.53506175 |
| 188 | glutamine metabolic process (GO:0006541) | 2.50774575 |
| 189 | hexose biosynthetic process (GO:0019319) | 2.49148271 |
| 190 | peptidyl-lysine dimethylation (GO:0018027) | 2.49096572 |
| 191 | nuclear envelope reassembly (GO:0031468) | 2.48813802 |
| 192 | mitotic nuclear envelope reassembly (GO:0007084) | 2.48813802 |
| 193 | chromosome condensation (GO:0030261) | 2.47795636 |
| 194 | purine nucleobase biosynthetic process (GO:0009113) | 2.47000848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.58173753 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.05876142 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.02564316 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44483563 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.83402575 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.83392882 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.59013591 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.00299913 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.83158210 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.78498225 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.19135967 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.18000077 |
| 13 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.00493725 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.73229201 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.48934790 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.45581887 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.43948018 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.27888007 |
| 19 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.23574377 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19149805 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18316029 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18112043 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.12872759 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02607245 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94857657 |
| 26 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.93861565 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.86128730 |
| 28 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.80124363 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.79195611 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77244079 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.73682740 |
| 32 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.66886929 |
| 33 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.65503515 |
| 34 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55361640 |
| 35 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53290938 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53226455 |
| 37 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49829576 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.49554907 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49510689 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42513440 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42150600 |
| 42 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.35009040 |
| 43 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33482795 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32784591 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31325171 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.30792120 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.29186516 |
| 48 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27744582 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25049644 |
| 50 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23575224 |
| 51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22358407 |
| 52 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21132796 |
| 53 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.21058577 |
| 54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17351524 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17035715 |
| 56 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16303987 |
| 57 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.14686857 |
| 58 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13982337 |
| 59 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13818660 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13809774 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13808240 |
| 62 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13270502 |
| 63 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12845513 |
| 64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12164090 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11774829 |
| 66 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.11572501 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11529449 |
| 68 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.09950782 |
| 69 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09163189 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08595035 |
| 71 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07361939 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06619044 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06353807 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04115956 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03062580 |
| 76 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02808092 |
| 77 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.02647577 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02293386 |
| 79 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02157733 |
| 80 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01175931 |
| 81 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00877436 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99970069 |
| 83 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98860157 |
| 84 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97074919 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96107673 |
| 86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95916183 |
| 87 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95529615 |
| 88 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94681615 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94545822 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93558452 |
| 91 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93486356 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91321673 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90669877 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89617081 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89149432 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88311004 |
| 97 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.87726634 |
| 98 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.87324181 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86669818 |
| 100 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.86176013 |
| 101 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85415714 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84715465 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84715465 |
| 104 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82927479 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82645947 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82110954 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80562186 |
| 108 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80543402 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80497279 |
| 110 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.79159967 |
| 111 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.77125269 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75751883 |
| 113 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.74885875 |
| 114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.72718928 |
| 115 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.72566916 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70242684 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.69725467 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68758596 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.68632444 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.68266085 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.67638192 |
| 122 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.67340071 |
| 123 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.65827517 |
| 124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.65217183 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.65025098 |
| 126 | P68_20966046_ChIP-Seq_HELA_Human | 0.64770577 |
| 127 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64528309 |
| 128 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.64448440 |
| 129 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.63729652 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63224088 |
| 131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63135703 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62323908 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.62275722 |
| 134 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.62176585 |
| 135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60994194 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60464291 |
| 137 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.59452703 |
| 138 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.58830247 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58384141 |
| 140 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.57470846 |
| 141 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.56783408 |
| 142 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56721300 |
| 143 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.56275698 |
| 144 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.56034474 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55969928 |
| 146 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55962446 |
| 147 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55282820 |
| 148 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.55103014 |
| 149 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54742940 |
| 150 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.53483554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.47741849 |
| 2 | MP0005360_urolithiasis | 5.96116920 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.25089463 |
| 4 | MP0005365_abnormal_bile_salt | 4.93803251 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.53959006 |
| 6 | MP0010094_abnormal_chromosome_stability | 4.26026753 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.83011995 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.74412600 |
| 9 | MP0003111_abnormal_nucleus_morphology | 3.60279055 |
| 10 | MP0003252_abnormal_bile_duct | 3.28148282 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.25987367 |
| 12 | MP0003646_muscle_fatigue | 3.01271965 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.95734086 |
| 14 | MP0009840_abnormal_foam_cell | 2.87215676 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.87093208 |
| 16 | MP0005332_abnormal_amino_acid | 2.84134498 |
| 17 | MP0008058_abnormal_DNA_repair | 2.82094904 |
| 18 | MP0003077_abnormal_cell_cycle | 2.81724994 |
| 19 | MP0003195_calcinosis | 2.63641838 |
| 20 | MP0008057_abnormal_DNA_replication | 2.63612589 |
| 21 | MP0005083_abnormal_biliary_tract | 2.39672469 |
| 22 | MP0005670_abnormal_white_adipose | 2.23166668 |
| 23 | MP0008932_abnormal_embryonic_tissue | 2.21604529 |
| 24 | * MP0006036_abnormal_mitochondrial_physio | 2.16778818 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.16620575 |
| 26 | MP0004130_abnormal_muscle_cell | 2.05780321 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.00606675 |
| 28 | MP0000609_abnormal_liver_physiology | 1.95146124 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.94468358 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.94299164 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.93665165 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.89608532 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.89138878 |
| 34 | MP0001730_embryonic_growth_arrest | 1.87487622 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.74038936 |
| 36 | MP0003186_abnormal_redox_activity | 1.65095744 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.62386410 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.61969727 |
| 39 | * MP0005330_cardiomyopathy | 1.61512946 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59486387 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.59259402 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.57084370 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.56940908 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.56475968 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.56378290 |
| 46 | MP0001764_abnormal_homeostasis | 1.55088666 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.50473293 |
| 48 | MP0000751_myopathy | 1.49400333 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.48653125 |
| 50 | * MP0001672_abnormal_embryogenesis/_devel | 1.45488875 |
| 51 | * MP0005380_embryogenesis_phenotype | 1.45488875 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.45058371 |
| 53 | MP0002269_muscular_atrophy | 1.43517922 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.40329569 |
| 55 | MP0003786_premature_aging | 1.39915393 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.39682464 |
| 57 | MP0000749_muscle_degeneration | 1.39318523 |
| 58 | * MP0003984_embryonic_growth_retardation | 1.36451608 |
| 59 | * MP0002080_prenatal_lethality | 1.33258268 |
| 60 | MP0001697_abnormal_embryo_size | 1.32654017 |
| 61 | MP0003868_abnormal_feces_composition | 1.31272902 |
| 62 | * MP0002088_abnormal_embryonic_growth/wei | 1.30830742 |
| 63 | MP0003283_abnormal_digestive_organ | 1.27795500 |
| 64 | MP0005266_abnormal_metabolism | 1.21442978 |
| 65 | MP0005501_abnormal_skin_physiology | 1.21408825 |
| 66 | MP0004043_abnormal_pH_regulation | 1.21168745 |
| 67 | * MP0006035_abnormal_mitochondrial_morpho | 1.15433479 |
| 68 | MP0002971_abnormal_brown_adipose | 1.14927785 |
| 69 | * MP0004087_abnormal_muscle_fiber | 1.14299186 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.13636806 |
| 71 | MP0000598_abnormal_liver_morphology | 1.11924585 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.11593697 |
| 73 | MP0001346_abnormal_lacrimal_gland | 1.11186440 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.10701905 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.10265838 |
| 76 | MP0002098_abnormal_vibrissa_morphology | 1.09389379 |
| 77 | MP0000313_abnormal_cell_death | 1.07907721 |
| 78 | MP0010307_abnormal_tumor_latency | 1.07778767 |
| 79 | MP0002249_abnormal_larynx_morphology | 1.06749096 |
| 80 | MP0001873_stomach_inflammation | 1.06480974 |
| 81 | * MP0001544_abnormal_cardiovascular_syste | 1.05053748 |
| 82 | * MP0005385_cardiovascular_system_phenoty | 1.05053748 |
| 83 | MP0002160_abnormal_reproductive_system | 1.03257619 |
| 84 | MP0009697_abnormal_copulation | 1.03099855 |
| 85 | MP0000747_muscle_weakness | 1.02990519 |
| 86 | MP0005451_abnormal_body_composition | 1.02237875 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 1.01288141 |
| 88 | MP0004197_abnormal_fetal_growth/weight/ | 0.99816704 |
| 89 | MP0010030_abnormal_orbit_morphology | 0.98190207 |
| 90 | * MP0000358_abnormal_cell_content/ | 0.96808241 |
| 91 | * MP0003221_abnormal_cardiomyocyte_apopto | 0.96736618 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.96140823 |
| 93 | MP0000467_abnormal_esophagus_morphology | 0.96069477 |
| 94 | MP0004233_abnormal_muscle_weight | 0.95912397 |
| 95 | * MP0002972_abnormal_cardiac_muscle | 0.95473777 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.94369352 |
| 97 | MP0000750_abnormal_muscle_regeneration | 0.92382927 |
| 98 | * MP0010630_abnormal_cardiac_muscle | 0.92308631 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.92267919 |
| 100 | MP0005535_abnormal_body_temperature | 0.90885835 |
| 101 | MP0002085_abnormal_embryonic_tissue | 0.90768745 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.90599620 |
| 103 | MP0002084_abnormal_developmental_patter | 0.90562398 |
| 104 | * MP0005620_abnormal_muscle_contractility | 0.90133420 |
| 105 | MP0004858_abnormal_nervous_system | 0.89641180 |
| 106 | MP0002086_abnormal_extraembryonic_tissu | 0.88234266 |
| 107 | MP0005408_hypopigmentation | 0.87718411 |
| 108 | MP0005334_abnormal_fat_pad | 0.85747849 |
| 109 | MP0002210_abnormal_sex_determination | 0.85198722 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.81351885 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.80600011 |
| 112 | MP0009763_increased_sensitivity_to | 0.80184625 |
| 113 | MP0001756_abnormal_urination | 0.80109167 |
| 114 | * MP0006138_congestive_heart_failure | 0.78763465 |
| 115 | MP0005647_abnormal_sex_gland | 0.78757934 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.78559895 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.77423706 |
| 118 | MP0000733_abnormal_muscle_development | 0.77242468 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.75357193 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.75323778 |
| 121 | MP0000579_abnormal_nail_morphology | 0.75051412 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.74688693 |
| 123 | MP0001727_abnormal_embryo_implantation | 0.72832723 |
| 124 | MP0000537_abnormal_urethra_morphology | 0.71894958 |
| 125 | MP0001929_abnormal_gametogenesis | 0.71354885 |
| 126 | MP0004147_increased_porphyrin_level | 0.70254931 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.68516017 |
| 128 | MP0002938_white_spotting | 0.67838487 |
| 129 | MP0002796_impaired_skin_barrier | 0.67765821 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.67324056 |
| 131 | MP0001145_abnormal_male_reproductive | 0.66076672 |
| 132 | MP0002970_abnormal_white_adipose | 0.65949476 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.65501867 |
| 134 | MP0008469_abnormal_protein_level | 0.65325922 |
| 135 | MP0001661_extended_life_span | 0.63148050 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.62455678 |
| 137 | MP0009672_abnormal_birth_weight | 0.62378803 |
| 138 | MP0000604_amyloidosis | 0.61967635 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.60993065 |
| 140 | MP0003011_delayed_dark_adaptation | 0.59470702 |
| 141 | MP0005448_abnormal_energy_balance | 0.58385112 |
| 142 | MP0009115_abnormal_fat_cell | 0.55353663 |
| 143 | MP0005369_muscle_phenotype | 0.54296407 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.54211348 |
| 145 | MP0004085_abnormal_heartbeat | 0.53664942 |
| 146 | MP0009764_decreased_sensitivity_to | 0.53282606 |
| 147 | MP0003953_abnormal_hormone_level | 0.52425710 |
| 148 | MP0003566_abnormal_cell_adhesion | 0.51546634 |
| 149 | MP0003567_abnormal_fetal_cardiomyocyte | 0.51135050 |
| 150 | MP0004484_altered_response_of | 0.51017631 |
| 151 | MP0003718_maternal_effect | 0.50668609 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.48958277 |
| 153 | MP0005165_increased_susceptibility_to | 0.45478266 |
| 154 | MP0003329_amyloid_beta_deposits | 0.45193972 |
| 155 | MP0008961_abnormal_basal_metabolism | 0.44503394 |
| 156 | MP0005084_abnormal_gallbladder_morpholo | 0.44085619 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.43012459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.14976066 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.10813116 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.10675942 |
| 4 | Hyperglycinuria (HP:0003108) | 4.93570380 |
| 5 | Hyperammonemia (HP:0001987) | 4.81077062 |
| 6 | Ketosis (HP:0001946) | 4.77534154 |
| 7 | Xanthomatosis (HP:0000991) | 4.70619698 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.67561111 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.65286406 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.49294878 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.49294878 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.41581965 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.38847858 |
| 14 | Ketoacidosis (HP:0001993) | 4.37315996 |
| 15 | Hyperglycinemia (HP:0002154) | 4.26266027 |
| 16 | Myoglobinuria (HP:0002913) | 4.02382329 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.98200660 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 3.93735645 |
| 19 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.93735645 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.90956916 |
| 21 | Progressive muscle weakness (HP:0003323) | 3.84946326 |
| 22 | Testicular atrophy (HP:0000029) | 3.83322442 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.77374595 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.74753535 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.62370182 |
| 26 | Complement deficiency (HP:0004431) | 3.53115715 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.49136154 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.41120458 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.36502851 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.34073644 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.31716834 |
| 32 | Cerebral edema (HP:0002181) | 3.30173796 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.26772940 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.26673850 |
| 35 | Epidermoid cyst (HP:0200040) | 3.26353511 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 3.25031481 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19201214 |
| 38 | Hepatic necrosis (HP:0002605) | 3.18927356 |
| 39 | Lethargy (HP:0001254) | 3.17298182 |
| 40 | Gout (HP:0001997) | 3.15392735 |
| 41 | Chromsome breakage (HP:0040012) | 3.13727716 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.08709347 |
| 43 | Metabolic acidosis (HP:0001942) | 3.04182928 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 3.00522864 |
| 45 | Myopathic facies (HP:0002058) | 3.00113657 |
| 46 | Muscle fiber inclusion bodies (HP:0100299) | 2.93029678 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.92858787 |
| 48 | Birth length less than 3rd percentile (HP:0003561) | 2.92780430 |
| 49 | Hyperacusis (HP:0010780) | 2.87555281 |
| 50 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.83516461 |
| 51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.81135834 |
| 52 | Joint hemorrhage (HP:0005261) | 2.77627236 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.75350680 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73307283 |
| 55 | Nemaline bodies (HP:0003798) | 2.73283287 |
| 56 | Fat malabsorption (HP:0002630) | 2.73163149 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.73100144 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.72250621 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.69220488 |
| 60 | Delayed CNS myelination (HP:0002188) | 2.69097176 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.67866589 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.64230256 |
| 63 | Nausea (HP:0002018) | 2.64052499 |
| 64 | Squamous cell carcinoma (HP:0002860) | 2.62142695 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.61762721 |
| 66 | Late onset (HP:0003584) | 2.61303378 |
| 67 | Unilateral renal agenesis (HP:0000122) | 2.60403158 |
| 68 | Palpitations (HP:0001962) | 2.58471501 |
| 69 | Progressive external ophthalmoplegia (HP:0000590) | 2.57815008 |
| 70 | Abnormality of complement system (HP:0005339) | 2.52770142 |
| 71 | Vomiting (HP:0002013) | 2.50291569 |
| 72 | Poikiloderma (HP:0001029) | 2.45505875 |
| 73 | Acute encephalopathy (HP:0006846) | 2.45217735 |
| 74 | Ragged-red muscle fibers (HP:0003200) | 2.42870467 |
| 75 | Hypercholesterolemia (HP:0003124) | 2.40740949 |
| 76 | Sudden death (HP:0001699) | 2.39792082 |
| 77 | Cholelithiasis (HP:0001081) | 2.39475036 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.39452216 |
| 79 | Skin nodule (HP:0200036) | 2.35514588 |
| 80 | Increased purine levels (HP:0004368) | 2.35299266 |
| 81 | Hyperuricemia (HP:0002149) | 2.35299266 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.34321579 |
| 83 | Neonatal onset (HP:0003623) | 2.33168858 |
| 84 | Reticulocytopenia (HP:0001896) | 2.33159757 |
| 85 | Breast hypoplasia (HP:0003187) | 2.30682999 |
| 86 | Hepatocellular necrosis (HP:0001404) | 2.30364483 |
| 87 | Achilles tendon contracture (HP:0001771) | 2.29917218 |
| 88 | Lactic acidosis (HP:0003128) | 2.28572327 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 2.27731614 |
| 90 | Spastic diplegia (HP:0001264) | 2.25997303 |
| 91 | Renal cortical cysts (HP:0000803) | 2.25077864 |
| 92 | Hyperglycemia (HP:0003074) | 2.23290153 |
| 93 | Calcaneovalgus deformity (HP:0001848) | 2.20999173 |
| 94 | Dysmetric saccades (HP:0000641) | 2.20839185 |
| 95 | Ventricular tachycardia (HP:0004756) | 2.20283106 |
| 96 | Entropion (HP:0000621) | 2.20185530 |
| 97 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.18454043 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 2.17909823 |
| 99 | Abnormality of reticulocytes (HP:0004312) | 2.15635212 |
| 100 | Abnormal number of erythroid precursors (HP:0012131) | 2.15513232 |
| 101 | Abnormality of glycolysis (HP:0004366) | 2.15374301 |
| 102 | Increased serum pyruvate (HP:0003542) | 2.15374301 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 2.14950127 |
| 104 | Hyperalaninemia (HP:0003348) | 2.14950127 |
| 105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14950127 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 2.13698700 |
| 107 | Hydroxyprolinuria (HP:0003080) | 2.13698700 |
| 108 | Increased serum lactate (HP:0002151) | 2.12659961 |
| 109 | Insomnia (HP:0100785) | 2.11372611 |
| 110 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.10547952 |
| 111 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.10547952 |
| 112 | Right ventricular cardiomyopathy (HP:0011663) | 2.10296758 |
| 113 | Reticulocytosis (HP:0001923) | 2.07334112 |
| 114 | Septate vagina (HP:0001153) | 2.07024118 |
| 115 | Conjugated hyperbilirubinemia (HP:0002908) | 2.06178394 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 2.05291970 |
| 117 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.05247722 |
| 118 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01782341 |
| 119 | Cutaneous melanoma (HP:0012056) | 2.00873273 |
| 120 | Asymmetric septal hypertrophy (HP:0001670) | 1.98545732 |
| 121 | Abnormality of urine glucose concentration (HP:0011016) | 1.97757715 |
| 122 | Glycosuria (HP:0003076) | 1.97757715 |
| 123 | Type I transferrin isoform profile (HP:0003642) | 1.97575823 |
| 124 | Irritability (HP:0000737) | 1.97518016 |
| 125 | Methylmalonic aciduria (HP:0012120) | 1.96095095 |
| 126 | Microretrognathia (HP:0000308) | 1.95616065 |
| 127 | Steatorrhea (HP:0002570) | 1.94679242 |
| 128 | Pancreatitis (HP:0001733) | 1.94178795 |
| 129 | Muscle stiffness (HP:0003552) | 1.93587427 |
| 130 | Ependymoma (HP:0002888) | 1.93566674 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 1.93190677 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.92242398 |
| 133 | Cholecystitis (HP:0001082) | 1.92242398 |
| 134 | Atrioventricular block (HP:0001678) | 1.92144477 |
| 135 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91948894 |
| 136 | Lipoatrophy (HP:0100578) | 1.91936266 |
| 137 | Patellar aplasia (HP:0006443) | 1.90916971 |
| 138 | Myocardial infarction (HP:0001658) | 1.90281382 |
| 139 | Sparse lateral eyebrow (HP:0005338) | 1.89507218 |
| 140 | Dilated cardiomyopathy (HP:0001644) | 1.89397608 |
| 141 | Abnormality of the calcaneus (HP:0008364) | 1.88190312 |
| 142 | Opisthotonus (HP:0002179) | 1.88127449 |
| 143 | Trismus (HP:0000211) | 1.86654284 |
| 144 | Multiple enchondromatosis (HP:0005701) | 1.86035199 |
| 145 | Exercise intolerance (HP:0003546) | 1.85760897 |
| 146 | Deformed tarsal bones (HP:0008119) | 1.84903550 |
| 147 | Increased intramyocellular lipid droplets (HP:0012240) | 1.81643888 |
| 148 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.81394403 |
| 149 | Abnormality of the preputium (HP:0100587) | 1.78445725 |
| 150 | Reduced antithrombin III activity (HP:0001976) | 1.76317255 |
| 151 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.70921358 |
| 152 | High pitched voice (HP:0001620) | 1.69297260 |
| 153 | Spastic paraparesis (HP:0002313) | 1.68438184 |
| 154 | Adducted thumb (HP:0001181) | 1.66528030 |
| 155 | Increased connective tissue (HP:0009025) | 1.65372397 |
| 156 | EMG: myopathic abnormalities (HP:0003458) | 1.64873000 |
| 157 | Abnormal protein glycosylation (HP:0012346) | 1.61734669 |
| 158 | Abnormal glycosylation (HP:0012345) | 1.61734669 |
| 159 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.61734669 |
| 160 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.61734669 |
| 161 | Selective tooth agenesis (HP:0001592) | 1.61581561 |
| 162 | Abnormality of the gallbladder (HP:0005264) | 1.61522116 |
| 163 | Abnormality of DNA repair (HP:0003254) | 1.60558066 |
| 164 | Distal lower limb amyotrophy (HP:0008944) | 1.60531696 |
| 165 | Melanoma (HP:0002861) | 1.57852176 |
| 166 | Back pain (HP:0003418) | 1.57469678 |
| 167 | Neoplasm of the adrenal gland (HP:0100631) | 1.56087888 |
| 168 | Rough bone trabeculation (HP:0100670) | 1.55415088 |
| 169 | Self-mutilation (HP:0000742) | 1.55321752 |
| 170 | Increased nuchal translucency (HP:0010880) | 1.55314061 |
| 171 | Ulnar bowing (HP:0003031) | 1.54858791 |
| 172 | Abnormality of the carotid arteries (HP:0005344) | 1.52710814 |
| 173 | Type 1 muscle fiber predominance (HP:0003803) | 1.52538691 |
| 174 | Elfin facies (HP:0004428) | 1.52468575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.87412060 |
| 2 | SMG1 | 4.04379327 |
| 3 | PDK4 | 3.65549802 |
| 4 | PDK3 | 3.65549802 |
| 5 | TRIB3 | 3.65545469 |
| 6 | PKN2 | 3.62726126 |
| 7 | NEK1 | 3.01980802 |
| 8 | PDK2 | 2.95252409 |
| 9 | ICK | 2.95045326 |
| 10 | STK38L | 2.91171075 |
| 11 | ERN1 | 2.83282573 |
| 12 | BUB1 | 2.63035797 |
| 13 | FLT3 | 2.61945237 |
| 14 | CDC7 | 2.54230625 |
| 15 | VRK2 | 2.49155326 |
| 16 | TTN | 2.44813705 |
| 17 | SIK1 | 2.22509779 |
| 18 | CDK12 | 2.14364466 |
| 19 | LMTK2 | 2.05852547 |
| 20 | OBSCN | 2.05107335 |
| 21 | NEK9 | 1.82721790 |
| 22 | FGFR4 | 1.79285753 |
| 23 | PBK | 1.78652104 |
| 24 | PINK1 | 1.73023828 |
| 25 | INSRR | 1.69444363 |
| 26 | CDK8 | 1.67223275 |
| 27 | SRPK1 | 1.55837193 |
| 28 | MAP3K7 | 1.54162094 |
| 29 | PHKG2 | 1.52584367 |
| 30 | PHKG1 | 1.52584367 |
| 31 | NME1 | 1.51871443 |
| 32 | CDK7 | 1.40759824 |
| 33 | ATR | 1.37861868 |
| 34 | MAPK11 | 1.36342271 |
| 35 | CHEK2 | 1.33174468 |
| 36 | MAP2K3 | 1.30972894 |
| 37 | PIK3CA | 1.29800926 |
| 38 | TESK2 | 1.29620697 |
| 39 | MAPKAPK5 | 1.27698492 |
| 40 | MUSK | 1.27406514 |
| 41 | MYLK | 1.23654720 |
| 42 | ERBB4 | 1.18517691 |
| 43 | MAPKAPK3 | 1.14728779 |
| 44 | AURKA | 1.13753317 |
| 45 | MAP3K3 | 1.12380341 |
| 46 | PIM2 | 1.04634116 |
| 47 | TIE1 | 0.96659605 |
| 48 | CHEK1 | 0.96513201 |
| 49 | PLK1 | 0.95861509 |
| 50 | PRKAA2 | 0.95240379 |
| 51 | KDR | 0.95156549 |
| 52 | AURKB | 0.94023680 |
| 53 | SCYL2 | 0.92204928 |
| 54 | TAF1 | 0.88666711 |
| 55 | STK38 | 0.87499987 |
| 56 | MAP2K4 | 0.85779462 |
| 57 | BRSK1 | 0.84688330 |
| 58 | NEK2 | 0.83546880 |
| 59 | CDK4 | 0.81991120 |
| 60 | PTK6 | 0.81139241 |
| 61 | PRKAA1 | 0.79181537 |
| 62 | LATS2 | 0.77448450 |
| 63 | TLK1 | 0.76358292 |
| 64 | DMPK | 0.76200266 |
| 65 | MAP3K11 | 0.75508357 |
| 66 | EEF2K | 0.74406171 |
| 67 | PIK3CG | 0.73997894 |
| 68 | TTK | 0.72942982 |
| 69 | LATS1 | 0.72829540 |
| 70 | STK4 | 0.71809484 |
| 71 | ARAF | 0.71418235 |
| 72 | ZAK | 0.71044398 |
| 73 | PDPK1 | 0.68293632 |
| 74 | MELK | 0.68171807 |
| 75 | CCNB1 | 0.68107725 |
| 76 | NME2 | 0.67862353 |
| 77 | MAPK12 | 0.67792056 |
| 78 | EIF2AK1 | 0.67661016 |
| 79 | MAP3K5 | 0.67109662 |
| 80 | TYK2 | 0.66067098 |
| 81 | WNK4 | 0.65040840 |
| 82 | PAK4 | 0.63954964 |
| 83 | PDK1 | 0.63396948 |
| 84 | WEE1 | 0.62999789 |
| 85 | ABL2 | 0.62961895 |
| 86 | MAP2K1 | 0.60670458 |
| 87 | PRKCI | 0.60595281 |
| 88 | JAK2 | 0.60057571 |
| 89 | CDK2 | 0.57323234 |
| 90 | CDK1 | 0.56694277 |
| 91 | RAF1 | 0.56472983 |
| 92 | ILK | 0.54669740 |
| 93 | TAOK3 | 0.53883524 |
| 94 | DAPK1 | 0.53164084 |
| 95 | SGK3 | 0.52005477 |
| 96 | STK24 | 0.51934058 |
| 97 | MAP3K9 | 0.51208570 |
| 98 | LRRK2 | 0.50886876 |
| 99 | IRAK3 | 0.50245133 |
| 100 | PRKACG | 0.50080561 |
| 101 | ATM | 0.49428163 |
| 102 | PASK | 0.49342197 |
| 103 | MAP2K6 | 0.49125592 |
| 104 | EPHA2 | 0.48276274 |
| 105 | CDK9 | 0.47229210 |
| 106 | TGFBR1 | 0.46762010 |
| 107 | MTOR | 0.46735964 |
| 108 | TAOK1 | 0.43783505 |
| 109 | ACVR1B | 0.42394329 |
| 110 | MAP3K8 | 0.41922617 |
| 111 | RPS6KA5 | 0.41869006 |
| 112 | AKT2 | 0.41721546 |
| 113 | PRKD3 | 0.40273298 |
| 114 | PAK3 | 0.39276971 |
| 115 | MST1R | 0.38003593 |
| 116 | RPS6KB1 | 0.36236360 |
| 117 | BRAF | 0.35555905 |
| 118 | SIK2 | 0.35287047 |
| 119 | VRK1 | 0.32446038 |
| 120 | SGK2 | 0.32406401 |
| 121 | FER | 0.31874593 |
| 122 | PRKACB | 0.31316772 |
| 123 | RPS6KB2 | 0.30658480 |
| 124 | RIPK1 | 0.30586584 |
| 125 | TAOK2 | 0.29955054 |
| 126 | MAP2K2 | 0.29811654 |
| 127 | RPS6KA1 | 0.29665918 |
| 128 | CAMK2G | 0.29618384 |
| 129 | PRKD1 | 0.29221736 |
| 130 | MAPK14 | 0.28088797 |
| 131 | PAK2 | 0.27943183 |
| 132 | CSNK1E | 0.27774530 |
| 133 | CSNK2A2 | 0.26974871 |
| 134 | TSSK6 | 0.26648765 |
| 135 | PLK4 | 0.26210277 |
| 136 | CLK1 | 0.25653304 |
| 137 | CDK6 | 0.25270226 |
| 138 | PRPF4B | 0.25164741 |
| 139 | TGFBR2 | 0.24404945 |
| 140 | NUAK1 | 0.24378200 |
| 141 | MAPK4 | 0.23313248 |
| 142 | KSR2 | 0.23271365 |
| 143 | EIF2AK3 | 0.22710450 |
| 144 | PRKG2 | 0.22553672 |
| 145 | JAK1 | 0.22199176 |
| 146 | MAP3K10 | 0.21037560 |
| 147 | BRSK2 | 0.20753857 |
| 148 | GSK3A | 0.20198437 |
| 149 | DAPK3 | 0.20035961 |
| 150 | MET | 0.19603910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40508612 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.23781683 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.20729723 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.18537410 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.08812895 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.06679397 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.00023193 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99957629 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77223933 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73418708 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51634685 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48048103 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.43562133 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.35189276 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30480807 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.21642540 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21411622 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.19815151 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.14825109 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07819429 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.96862318 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95675987 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.94432444 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84766566 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.84370699 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.81689257 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79733859 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78044307 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.74842990 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73631895 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.70839020 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66991021 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.65403992 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.63713998 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63269348 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.55616591 |
| 37 | Cell cycle_Homo sapiens_hsa04110 | 1.49294513 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47678914 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46789709 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46675609 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45617973 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43452724 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38757194 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38310635 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35153850 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32717683 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31405284 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31164246 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29597540 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27373567 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26512019 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19986789 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16158975 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14741719 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12573833 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.09156003 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08666686 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07602904 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04842425 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04353178 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04089353 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02489498 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00934719 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98480952 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96427751 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93678889 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93661056 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93645507 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93641141 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92939499 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.87394569 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86469208 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.82280639 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81351925 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78865575 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.77518438 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72466025 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.71245257 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70216062 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67068344 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63664284 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59643410 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57600916 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53187603 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53092996 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51030145 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.50207166 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49393645 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48691183 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48428229 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47968477 |
| 92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.47775893 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42618282 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40985947 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39945072 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39055212 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35892755 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35548171 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34565771 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34151794 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29755531 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28482179 |
| 103 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26998448 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25818264 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25324621 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23155181 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22196252 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21644731 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18981314 |
| 110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.18836233 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17972016 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17819694 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13080126 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.07497984 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.06003647 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04842760 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.03774179 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.03093665 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.01119918 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.1116325 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | -0.1035467 |
| 122 | DNA replication_Homo sapiens_hsa03030 | -0.0882665 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0749209 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | -0.0709264 |
| 125 | Proteasome_Homo sapiens_hsa03050 | -0.0677451 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0671761 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0560438 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0177270 |

